Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia

Medical Decision Making

Volumn 16, Issue 3, 1996, Pages 262-272

  Llewellyn Thomas, Hilary A ^a,b   Williams, J Ivan ^a   Levy, Linda ^a   Naylor, C D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

benign prostatic hyperplasia; decision aids; patients' preferences; probabilities; risk aversion; utilities

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PROSTATE HYPERTROPHY; RATING SCALE; TRANSURETHRAL RESECTION;

AGED; CHOICE BEHAVIOR; DECISION SUPPORT TECHNIQUES; FEASIBILITY STUDIES; HUMANS; MALE; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; PATIENT SATISFACTION; PROSTATIC HYPERPLASIA; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS;

EID: 0029979778     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9601600311     Document Type: Article

References (45)

1. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med. 1994;330:1895-6.
2. O'Connor AM, Llewellyn-Thomas HA, Drake ER. An Annotated Bibliography of Research on Shared Decision Making. Toronto, Ont., Canada. National Cancer Institute of Canada. 1995
3. Llewellyn-Thomas HA. Patients' health care decision making: a framework for descriptive and experimental investigations. Med Decis Making. 1995;15:101-6
4. Naylor CD. Grey zones of clinical practice. some limits to evidence-based medicine Lancet 1995;343:840-2
5. Kasper JF, Mulley AG, Wennberg JE Developing shared decision making programs to improve the quality of health care. Qual Rev Bull 1992;1 183-90
6. Levine MN, Gafni A, Markham B, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992;117:53-8.
7. O'Connor A, Tugwell P, Wells G. Testing a portable, self-administered decision aid for post-menopausal women considering long-term hormone replacement therapy to prevent osteoporosis and heart disease (abstr). Med Decis Making. 1994;14:438.
8. Chapman GB, Elstein AS, Hughes KK. Effects of patient education on decisions about breast cancer treatments: a preliminary report. Med Decis Making. 1995;15:231-9.
9. Holmes-Rovner M. Evaluation standards for patient decision supports. Med Decis Making. 1995;15:2-3.
10. O'Connor A. Validation of a decisional conflict scale. Med Decis Making. 1995;15.25-30.
11. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia, PA: W. B. Saunders, 1980.
12. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Boston, MA: Butterworths, 1988.
13. Schoemaker PJH. Experiments on Decisions under Risk: The Expected Utility Hypothesis. Boston, MA: Kluwer-Nijhoff Publishing, 1980.
14. Fischhoff B, Goitein B, Shapira Z. The expected utility of expected utility approaches. In Feather NT (ed). Expectations and Actions: Expectancy-value Models in Psychology. Hillsdale, NJ: Lawrence Erlbaum, 1982.
15. Schoemaker PJH. The expected utility model: its variants, purposes, evidence and limitations. J Econ Lit. 1982;20:529-63.
16. Llewellyn-Thomas HA. Turning decision analysis around. Ann R Coll Physicians Surgeons Can. 1994;27:177-8.
17. O'Connor AMC, Boyd NF, Warde P, Stolbach L, Till JE. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preference. J Chronic Dis. 1987;40:811-8.
18. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and decision making preference. Soc Sci Med. 1991;32:35-42.
19. Llewellyn-Thomas HA, Thiel EC, Clark RM. Patients versus surrogates: whose opinion counts on ethics review panels? Clin Res 1989;37:501-5.
20. Palda VA, Llewellyn-Thomas HA, MacKenzie RG, Pritchard KI, Harrison-Woermke DE, Naylor CD. Breast cancer patients' perceptions of the effectiveness of radiation therapy. Med Decis Making (abstr). 1994;14:438.
21. Percy ME, Llewellyn-Thomas HA. Assessing preferences about the DNR order: does it depend on how you ask? Med Decis Making. 1995;15:209-16.
22. Llewellyn-Thomas HA, Paterson JM, Carter JA, Naylor CD. Cholesterol-lowering medication in primary prevention: do patients 'demand' realistic risk reduction? Med Decis Making (abstr) 1994;14:436.
23. Llewellyn-Thomas HA, Carter JA, Paterson JM, Naylor CD. Anti-hypertensive medication for primary prevention: are patients' risk reduction requirements realistic? (abstr). Med Decis Making. 1995;15:431.
24. Llewellyn-Thomas HA, Thiel EC, Naylor CD Waiting for elective CABG: patients' perceived risks and utilities for time. Med Decis Making (abstr) 1992;12:337.
25. Llewellyn-Thomas HA, Williams JI, Ashinoff R. Patients' "maximal acceptable time" waiting for total joint replacement. Theoret Surg (abstr). 1994;9:184.
26. Palda VA, Llewellyn-Thomas HA, MacKenzie RG, Pritchard KI, Harrison-Woermke DE, Naylor CD. Breast cancer patients' willingness to wait for, and forego, radiation therapy. Breast Cancer Res Treat (abstr). 1994;32(suppl):45,#68.
27. Naylor CD, Llewellyn-Thomas HA. Can there be a more patient-centered approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol. 1994;47:787-95.
28. O'Connor AM. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989;42:119-26.
29. Berry SJ, Coffey DS, Walsh PC. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9.
30. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. Urology. 1991(suppl);38:4-8.
31. Graverson PH, Gesser TC, Wasson JH, Hinman F, Bruskewitz RC. Controversies about indications for transurethral resection of the prostate. J Urol. 1989;141:475-81.
32. McPherson K, Wennberg JE, Hovind OB, et al. Small-area variation in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med. 1982;307:1310-14.
33. Wennberg JE, Mulley AG, Hanley D, et al. An evaluation of prostatectomy for benign urinary tract obstruction: geographic variations and the assessment of medical care outcomes. JAMA. 1988;259:3027-30.
34. Barry MJ, Mulley AG, Fowler FJ, et al. Watchful waiting versus immediate transurethral resection for symptomatic prostatism: the importance of patients' preferences. JAMA. 1988;259:3010-7
35. Barry MJ, Mulley AG, Hanley D, Fowler FJ, Wennberg JE, Timothy RP. Symptom status and quality of life following prostatectomy. JAMA. 1988;259:3018-22.
36. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research. Clinical Practice Guidelines for Benign Prostatic Hyperplasia: Diagnosis and Treatment. AHCPR Publication No. 94-0582. 1994.
37. Lyon HC, Henderson JV, Beck JR, et al. A multipurpose interactive videodisc with ethical, legal, medical, educational and research implications: the informed patient decision-making procedure. In Kingsland LC (ed). Proceedings of the 13th Annual Symposium on Computer Applications in Medical Care, Nov 5-8, 1989, Washington, DC. IEEE Computer Society. 1989;1043-5.
38. Greengard S. The physician's new care comparison: interactive videodiscs expand the patient's role in making treatment decisions. Am Med News. June 29, 1992:7-8.
39. National Institutes of Health. Normal Human Aging: The Baltimore Longitudinal Study of Aging, Nov 1984, Washington, DC. US GPO (NIH Publication No 84 - 2450).
40. Patrick DL, Bush JW, Chen MM. Methods for measuring levels of well-being for a health status index. Health Serv Res. 1973;8:228-45.
41. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement technique. Soc-Econ Planning Sci. 1976;10:129-36.
42. Froberg DG, Kane RL. Methodology for measuring health state preferences - II: Scaling methods. J Clin Epidemiol. 1989;42:459-71.
43. Nichol G, Llewellyn-Thomas HA, Thiel EC, Naylor CD. The relationship between cardiac functional capacity and patients' symptom-specific utilities for angina: some findings and methodologic issues. Med Decis Making. 1996;16:78-85.
44. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research. Benign Prostatic Hyperplasia Patient Guide: "Treating Your Enlarged Prostate." AHCPR Publication No. 94-0584. 1994.
45. Llewellyn-Thomas HA, Arshinoff R, Bell M, Williams JI, Naylor CD. A longitudinal study of patients undergoing major joint replacement surgery: anticipated and actual relief of arthritic distress. (Manuscript under review).